Crossmark

Tumor suppressor miR-145-5p sensitizes prolactinoma to bromocriptine by downregulating TPT1

Crossref DOI link: https://doi.org/10.1007/s40618-018-0963-4

Published Online: 2018-10-28

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jian, M.

Du, Q.

Zhu, D.

Mao, Z.

Wang, X.

Feng, Y.

Xiao, Z.

Wang, H.

Zhu, Y.
Funding

Funding for this research was provided by:

National Nature and Science Grant of China (81773943)

Science and Technology Planning Project of Guangdong Province (2017A050501011)

Science and Technology Planning Project of Guangdong Province (2014A020212076)

Guangzhou Science and Technology Project (No.201704020085)

Sun Yat-sen University Clinical Research 5010 (2016008)
License Information

Text and Data Mining valid from 2018-10-28
More Information

Article History

Received: 23 January 2018

Accepted: 1 October 2018

First Online: 28 October 2018

Compliance with ethical standards

:

: The authors declare that they have no competing interests.

: Ethics approval for the project was obtained from the Human Research Ethics Committee of Sun Yat-sen University. Patient consent for the use of the samples in this project was obtained in the format stipulated by the committee.

: Informed consent was obtained from all individual participants in this study.